the efficacy of intravenous nimodipine ( used at the rate of 2 mg.h-1 ) was investigated in the treatment of delayed ischemic deterioration or angiographic vasospasm after subarachnoid haemorrhage caused by a ruptured aneurysm in a randomized , double-blind , placebo-controlled multicenter study .
C0028094
nimodipine
C0038525
subarachnoid haemorrhage